InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
2
T+90 hit rate
13%
T+90 mean return
-15.0%
Across 8 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Iannone Robert, Directeur Médical. Officer active across 1 company, notably Jazz Pharmaceuticals plc. Cumulatively, 14 reports have been published. Split: 0 buy · 2 sells. Total volume traded: €571k. History available since 5 June 2021. The latest transaction was disclosed on 10 March 2025 (Cession). Regulator: SEC (Form 4). All data is free.
Declarations14 total
2,403 shares@ US$138.412212.7% of flowOrdinary SharesSEC:0001765581-25-000035:0
5,239 shares@ US$138.9528.4% of flowOrdinary SharesSEC:0001765581-25-000026:0
17,718 shares0Ordinary SharesSEC:0001765581-25-000020:0
7,506 shares0Ordinary SharesSEC:0001805688-25-000013:0
4,294 shares@ US$117.5319.3% of flowOrdinary SharesSEC:0001765581-24-000031:0
16,928 shares0Ordinary SharesSEC:0001765581-24-000017:0
5,970 shares0Ordinary SharesSEC:0001784606-24-000008:0
1,311 shares@ US$129.736.6% of flowOrdinary SharesSEC:0001765581-23-000048:0
12,447 shares0Ordinary SharesSEC:0001765581-23-000028:0
1,844 shares@ US$151.5411.0% of flowOrdinary SharesSEC:0001765581-22-000138:0
1,295 shares@ US$149.250.0013% mcap34.0% of flowOrdinary SharesSEC:0001765581-22-000061:0
11,374 shares0Ordinary SharesSEC:0001765581-22-000019:0
1,206 shares@ US$176.470.0012% mcap33.0% of flowOrdinary SharesSEC:0001765581-21-000063:0
1,206 shares@ US$176.477.3% of flowOrdinary SharesSEC:0001765581-21-000063
14 of 14 declarations
About Iannone Robert
Robert Iannone is the Chief Medical Officer and EVP, Global Head of R&D at Jazz Pharmaceuticals plc. He oversees the company's research and development initiatives, ensuring that projects align with strategic goals. His expertise in medical research and drug development is essential for innovation and improvement of treatments offered by Jazz Pharmaceuticals. He plays a key role in the scientific direction of the company.
